If You Invested in NKGen Biotech Inc (GFOR)
Looking for the current price? See the GFOR quote & overviewWhat $1,000 or $10,000 in GFOR Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 13, 2021 |
|---|---|---|---|---|
| $1,000 | — | $854 -15% | — | $856 -14% |
| $10,000 | — | $8,539 -15% | — | $8,557 -14% |
Based on real historical closing prices, dividend- and split-adjusted, through 2023-09-29. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for GFOR$1,000 Investment Over Time
GFOR vs S&P 500Year-by-Year Returns
GFOR annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021 | $9.70 | $9.69 | -0.1% | -0.1% |
| 2022 | $9.68 | $9.95 | +2.8% | +2.6% |
| 2023 | $9.95 | $8.30 | -16.6% | -14.4% |
About NKGen Biotech Inc
Frequently Asked Questions
NKGen Biotech Inc investment returns
How much would $1,000 invested in NKGen Biotech Inc be worth today?
If you invested $1,000 in NKGen Biotech Inc (GFOR) 5 years ago on 2021-09-13, your investment would be worth $854 as of 2023-09-29, representing a -14.6% total return, growing at a compounded rate of -7.4% per year (CAGR).
Has NKGen Biotech Inc outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare GFOR performance over available time periods.
What is NKGen Biotech Inc's average annual return?
The compound annual growth rate (CAGR) of GFOR over the past 5 years is -7.4%, growing at a compounded rate each year. Individual years vary significantly — GFOR's best recent year was 2022 (+2.8%) and worst was 2023 (-16.6%).
Your Privacy is Protected
This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.
For informational and educational purposes only — not investment advice.
